DV
Dividend Vision

CPIX — Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc (CPIX)

Its deepest 1-year drawdown was 48.5%.

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on acquiring, developing, and commercializing prescription products for hospital acute care, gastroenterology, and oncology markets. Its commercial portfolio includes injectable treatments for acetaminophen poisoning, pain and fever, nausea prevention in chemotherapy patients, bacterial infections, and other conditions, along with oral medications for constipation and H. pylori infection; the company also has a product candidate in clinical development for multiple rare and serious diseases. Cumberland's dividend distribution profile is not currently known.

CPIX key facts

Asset type
Stock
Asset class
Equity
Inception date
08/11/2009
Trailing yield
38.51%
Last close
$7.79
Market cap
$102,484,456
Average volume
57819.0
Last dividend
$1.5000
Ex-dividend date
07/23/2026
Payment date
07/31/2026
Beta
0.095
Payout ratio
0.0
Forward P/E
50.0
EPS
$-0.49